Method of Levels for People Using Community Crisis Services

December 16, 2022 updated by: Sara Goodier, University of Manchester

Is Method of Levels (MOL) an Acceptable and Feasible Psychological Intervention for People Using Community Based Crisis Services? A Case Series.

A mental health crisis is when someone is so distressed they need urgent help from services; often because they behave in ways that poses risk to themselves or others. Crisis teams offer care in the community to support people at home rather than in hospital. Current psychological interventions offered by crisis teams tend to be short-term and mainly involve providing information about the difficulties people are experiencing and help them to develop skills, such people as problem solving. This can be useful, however providing more intensive psychological support has been much more difficult within crisis settings, as teams must use limited resources to focus on managing risk. A therapy, called Method of Levels (MOL), designed to be flexible, may be helpful to add to treatment offered by crisis services in the community.

MOL aims to help people hold their attention on a problem long enough to view it in different ways, so that they might think of new solutions. This works by helping a person to regain a sense of control in their life and feel less distressed. MOL is useful for working with lots of different issues, since therapy does not only focus on one type of problem. People also get to choose what is discussed in therapy and session structure.

Research has shown MOL can be useful for people in crisis in places such as inpatient settings. So far, no research has been conducted within the community for people in crisis. This study aims to examine if MOL can be delivered within a crisis service in a way that is helpful and acceptable to people. To do this, the investigators will offer MOL to a small number of people presenting to crisis teams and collect information on whether people take up the therapy, and their experience of receiving it.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Manchester, United Kingdom, M139PL
        • University of Manchester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adults, aged over 18 years.
  2. Meet criteria for crisis services and currently working with the crisis team
  3. Able to provide informed consent (no queries regarding capacity)
  4. Willing to engage in psychological therapy.
  5. Ability to speak English fluently enough to provide informed consent and engage in therapy.

Exclusion Criteria:

  1. Inability to provide informed consent.
  2. Inability to speak English fluently enough to engage in therapy: As MOL is a therapy that relies on mobilising attention, the use of interpreters during therapy for non-English speakers may serve to alter the participants attention differently. This may confound results; as this is a preliminary case series, it would not be appropriate to include non-English speakers.
  3. Problems of an organic nature, or a learning disability that might affect cognitive functioning.
  4. Substance misuse as primary presenting problem.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Method of Levels Therapy
Method of levels therapy, see intervention details. All participants will receive therapy and must attend a minimum of one session for their data to be included in the study.

Method of Levels (MOL) is a therapy that is the direct application of Perceptual Control Theory (PCT) (Powers, 2008) which proposes that psychological distress results from a person's reduced control over important life goals. A conflict between two or more goals can occur outside of a person's awareness (Carey, Mansell & Tai, 2014) and the achievement of one goal leaves the other incompatible goal unachievable, leading to distress (Mansell, 2012). MOL therapy aims to help people develop awareness of important goals and conflicts between them, to increase their chances of developing potential solutions. Conflict can be resolved through reorganisation; a mechanism through which random change is continuously generated until control is restored (Tai, 2016).

Therapy uses a questioning style to help clients bring their attention to their problems long enough for them to restore control. In practice clients choose the number, frequency and duration of therapy sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate.
Time Frame: Length of study (up to one year)
Number of participants recruited into the study.
Length of study (up to one year)
Retention rate.
Time Frame: Length of study (up to one year)
Number of participants retained to the end of the study.
Length of study (up to one year)
Psychological Outcome Profiles.
Time Frame: Beginning of each therapy session for length of therapy (chosen by participant), up to 5 months
Quantitative measure to indicate acceptability. Total score between 0-20, where a lower score indicates a better outcome.
Beginning of each therapy session for length of therapy (chosen by participant), up to 5 months
Session Rating Scale.
Time Frame: End of each therapy session (chosen by participant), up to 5 months.
Quantitative measure to indicate acceptability.Total score between 0-40, where a lower score indicates a better outcome.
End of each therapy session (chosen by participant), up to 5 months.
Qualitative interviews
Time Frame: End of therapy, up to 5 months.
Thematic analysis of qualitative interviews following end of therapy.
End of therapy, up to 5 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Outcomes in Routine Evaluation Outcome Measure
Time Frame: On recruitment, monthly (up to 5 months), one month follow up
Questionnaire. Total score between 0-136, where a lower score indicates a better outcome.
On recruitment, monthly (up to 5 months), one month follow up
Reorganisation of Conflict Scale.
Time Frame: On recruitment, monthly (up to 5 months), one month follow up
Questionnaire. 22 self reported items, each on a scale of 0-100, where a lower score indicates a better outcome.
On recruitment, monthly (up to 5 months), one month follow up
Suicidal ideation Attributes Scale.
Time Frame: On recruitment, monthly (up to 5 months), one month follow up
Questionnaire. Total score of 0-50, where a higher score indicates more severe suicidal thoguhts.
On recruitment, monthly (up to 5 months), one month follow up
BBC Subjective Well-being scale (BBC-SWB) (Kinderman, Schwannauer, Pontin, & Tai, 2011).
Time Frame: On recruitment, monthly (up to 5 months), one month follow up
Questionnaire. 24 items scores on a 5 point likert scale, where 5 indiicates high wellbeing.
On recruitment, monthly (up to 5 months), one month follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sara Goodier, MSc, University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2022

Primary Completion (Anticipated)

February 1, 2023

Study Completion (Anticipated)

March 1, 2023

Study Registration Dates

First Submitted

July 27, 2022

First Submitted That Met QC Criteria

July 29, 2022

First Posted (Actual)

August 2, 2022

Study Record Updates

Last Update Posted (Estimate)

December 21, 2022

Last Update Submitted That Met QC Criteria

December 16, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 316034

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Individuals Presenting to Crisis Services

Clinical Trials on Method of Levels Therapy

3
Subscribe